nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminoglutethimide—CYP1A2—chronic obstructive pulmonary disease	0.492	1	CbGaD
Aminoglutethimide—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0666	0.183	CbGbCtD
Aminoglutethimide—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0666	0.183	CbGbCtD
Aminoglutethimide—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0522	0.143	CbGbCtD
Aminoglutethimide—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0425	0.117	CbGbCtD
Aminoglutethimide—Vascular resistance systemic—Salbutamol—chronic obstructive pulmonary disease	0.0303	0.336	CcSEcCtD
Aminoglutethimide—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0287	0.0788	CbGbCtD
Aminoglutethimide—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.028	0.0768	CbGbCtD
Aminoglutethimide—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0274	0.0752	CbGbCtD
Aminoglutethimide—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0244	0.067	CbGbCtD
Aminoglutethimide—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0143	0.0393	CbGbCtD
Aminoglutethimide—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0135	0.0371	CbGbCtD
Aminoglutethimide—CYP11A1—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.00353	0.0664	CbGpPWpGaD
Aminoglutethimide—Adrenal insufficiency—Prednisone—chronic obstructive pulmonary disease	0.00289	0.032	CcSEcCtD
Aminoglutethimide—CYP11A1—Metabolism of steroid hormones and vitamin D—GC—chronic obstructive pulmonary disease	0.00227	0.0426	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00215	0.0404	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00188	0.0352	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00166	0.0312	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of steroid hormones and vitamin D—GC—chronic obstructive pulmonary disease	0.0015	0.0282	CbGpPWpGaD
Aminoglutethimide—Hirsutism—Prednisolone—chronic obstructive pulmonary disease	0.00143	0.0159	CcSEcCtD
Aminoglutethimide—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00136	0.0255	CbGpPWpGaD
Aminoglutethimide—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.00113	0.0125	CcSEcCtD
Aminoglutethimide—Hirsutism—Prednisone—chronic obstructive pulmonary disease	0.00104	0.0115	CcSEcCtD
Aminoglutethimide—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00103	0.0193	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Corticotropin-releasing hormone—RAPGEF3—chronic obstructive pulmonary disease	0.00103	0.0193	CbGpPWpGaD
Aminoglutethimide—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.000984	0.0109	CcSEcCtD
Aminoglutethimide—Hypothyroidism—Prednisone—chronic obstructive pulmonary disease	0.000942	0.0104	CcSEcCtD
Aminoglutethimide—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000939	0.0104	CcSEcCtD
Aminoglutethimide—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.000936	0.0176	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.000862	0.0162	CbGpPWpGaD
Aminoglutethimide—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000858	0.00951	CcSEcCtD
Aminoglutethimide—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000842	0.00933	CcSEcCtD
Aminoglutethimide—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000812	0.00899	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000796	0.00882	CcSEcCtD
Aminoglutethimide—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000747	0.014	CbGpPWpGaD
Aminoglutethimide—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000714	0.00791	CcSEcCtD
Aminoglutethimide—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000709	0.00785	CcSEcCtD
Aminoglutethimide—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000703	0.00779	CcSEcCtD
Aminoglutethimide—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000688	0.0129	CbGpPWpGaD
Aminoglutethimide—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000687	0.00761	CcSEcCtD
Aminoglutethimide—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000687	0.00761	CcSEcCtD
Aminoglutethimide—CYP1A2—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000684	0.0128	CbGpPWpGaD
Aminoglutethimide—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000681	0.00755	CcSEcCtD
Aminoglutethimide—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00068	0.00754	CcSEcCtD
Aminoglutethimide—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.00068	0.0128	CbGpPWpGaD
Aminoglutethimide—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000677	0.0075	CcSEcCtD
Aminoglutethimide—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000673	0.00746	CcSEcCtD
Aminoglutethimide—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000663	0.00735	CcSEcCtD
Aminoglutethimide—CYP11A1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000653	0.0123	CbGpPWpGaD
Aminoglutethimide—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000642	0.00711	CcSEcCtD
Aminoglutethimide—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000638	0.012	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.00063	0.0118	CbGpPWpGaD
Aminoglutethimide—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000626	0.00694	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000619	0.00686	CcSEcCtD
Aminoglutethimide—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000582	0.0109	CbGpPWpGaD
Aminoglutethimide—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000572	0.00634	CcSEcCtD
Aminoglutethimide—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000572	0.00634	CcSEcCtD
Aminoglutethimide—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000572	0.00634	CcSEcCtD
Aminoglutethimide—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000569	0.00631	CcSEcCtD
Aminoglutethimide—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00056	0.00621	CcSEcCtD
Aminoglutethimide—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00054	0.00598	CcSEcCtD
Aminoglutethimide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00054	0.00598	CcSEcCtD
Aminoglutethimide—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000535	0.00593	CcSEcCtD
Aminoglutethimide—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000535	0.00593	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000531	0.00588	CcSEcCtD
Aminoglutethimide—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.00053	0.00996	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000528	0.00992	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000523	0.00983	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000517	0.00973	CbGpPWpGaD
Aminoglutethimide—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000512	0.00568	CcSEcCtD
Aminoglutethimide—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000512	0.00568	CcSEcCtD
Aminoglutethimide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00051	0.00565	CcSEcCtD
Aminoglutethimide—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000505	0.0056	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.0005	0.00554	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000499	0.00553	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000499	0.00553	CcSEcCtD
Aminoglutethimide—CYP2C19—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000494	0.00929	CbGpPWpGaD
Aminoglutethimide—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000493	0.00547	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000489	0.00542	CcSEcCtD
Aminoglutethimide—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000487	0.0054	CcSEcCtD
Aminoglutethimide—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000487	0.0054	CcSEcCtD
Aminoglutethimide—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000484	0.00536	CcSEcCtD
Aminoglutethimide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000481	0.00532	CcSEcCtD
Aminoglutethimide—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000477	0.00529	CcSEcCtD
Aminoglutethimide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000476	0.00528	CcSEcCtD
Aminoglutethimide—CYP2C19—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000475	0.00893	CbGpPWpGaD
Aminoglutethimide—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000472	0.00523	CcSEcCtD
Aminoglutethimide—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000464	0.00872	CbGpPWpGaD
Aminoglutethimide—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00046	0.0051	CcSEcCtD
Aminoglutethimide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000458	0.00507	CcSEcCtD
Aminoglutethimide—CYP11A1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000458	0.0086	CbGpPWpGaD
Aminoglutethimide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000454	0.00503	CcSEcCtD
Aminoglutethimide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000454	0.00503	CcSEcCtD
Aminoglutethimide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000451	0.005	CcSEcCtD
Aminoglutethimide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00045	0.00499	CcSEcCtD
Aminoglutethimide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000449	0.00498	CcSEcCtD
Aminoglutethimide—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000435	0.00483	CcSEcCtD
Aminoglutethimide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000435	0.00483	CcSEcCtD
Aminoglutethimide—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000433	0.0048	CcSEcCtD
Aminoglutethimide—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000433	0.0048	CcSEcCtD
Aminoglutethimide—CYP19A1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000432	0.00813	CbGpPWpGaD
Aminoglutethimide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000432	0.00479	CcSEcCtD
Aminoglutethimide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000428	0.00475	CcSEcCtD
Aminoglutethimide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000428	0.00474	CcSEcCtD
Aminoglutethimide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000428	0.00474	CcSEcCtD
Aminoglutethimide—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000427	0.00473	CcSEcCtD
Aminoglutethimide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000426	0.00471	CcSEcCtD
Aminoglutethimide—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000424	0.0047	CcSEcCtD
Aminoglutethimide—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000423	0.00795	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000417	0.00784	CbGpPWpGaD
Aminoglutethimide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000411	0.00456	CcSEcCtD
Aminoglutethimide—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000409	0.00453	CcSEcCtD
Aminoglutethimide—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000409	0.00769	CbGpPWpGaD
Aminoglutethimide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000404	0.00447	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000404	0.00447	CcSEcCtD
Aminoglutethimide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000403	0.00447	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000396	0.00438	CcSEcCtD
Aminoglutethimide—CYP1A2—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000395	0.00742	CbGpPWpGaD
Aminoglutethimide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000388	0.0043	CcSEcCtD
Aminoglutethimide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000388	0.0043	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000381	0.00423	CcSEcCtD
Aminoglutethimide—CYP19A1—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00038	0.00714	CbGpPWpGaD
Aminoglutethimide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00038	0.00421	CcSEcCtD
Aminoglutethimide—CYP11A1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000376	0.00707	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000367	0.0069	CbGpPWpGaD
Aminoglutethimide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000366	0.00406	CcSEcCtD
Aminoglutethimide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000362	0.00402	CcSEcCtD
Aminoglutethimide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000362	0.00402	CcSEcCtD
Aminoglutethimide—CYP2C19—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000359	0.00675	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000355	0.00668	CbGpPWpGaD
Aminoglutethimide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000355	0.00393	CcSEcCtD
Aminoglutethimide—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000355	0.00393	CcSEcCtD
Aminoglutethimide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000349	0.00386	CcSEcCtD
Aminoglutethimide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000349	0.00386	CcSEcCtD
Aminoglutethimide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000346	0.00383	CcSEcCtD
Aminoglutethimide—Rash—Formoterol—chronic obstructive pulmonary disease	0.000346	0.00383	CcSEcCtD
Aminoglutethimide—CYP2C19—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000345	0.00649	CbGpPWpGaD
Aminoglutethimide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000345	0.00383	CcSEcCtD
Aminoglutethimide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000345	0.00383	CcSEcCtD
Aminoglutethimide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000343	0.00381	CcSEcCtD
Aminoglutethimide—Headache—Formoterol—chronic obstructive pulmonary disease	0.000343	0.00381	CcSEcCtD
Aminoglutethimide—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000343	0.00644	CbGpPWpGaD
Aminoglutethimide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000342	0.00379	CcSEcCtD
Aminoglutethimide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000341	0.00378	CcSEcCtD
Aminoglutethimide—Rash—Montelukast—chronic obstructive pulmonary disease	0.000339	0.00375	CcSEcCtD
Aminoglutethimide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000338	0.00375	CcSEcCtD
Aminoglutethimide—Headache—Montelukast—chronic obstructive pulmonary disease	0.000336	0.00373	CcSEcCtD
Aminoglutethimide—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000334	0.00629	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000331	0.00622	CbGpPWpGaD
Aminoglutethimide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000329	0.00365	CcSEcCtD
Aminoglutethimide—CYP11A1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000327	0.00615	CbGpPWpGaD
Aminoglutethimide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000326	0.00362	CcSEcCtD
Aminoglutethimide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000326	0.00361	CcSEcCtD
Aminoglutethimide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000326	0.00361	CcSEcCtD
Aminoglutethimide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000326	0.00361	CcSEcCtD
Aminoglutethimide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.00359	CcSEcCtD
Aminoglutethimide—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000323	0.00608	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000321	0.00604	CbGpPWpGaD
Aminoglutethimide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000319	0.00353	CcSEcCtD
Aminoglutethimide—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.00031	0.00582	CbGpPWpGaD
Aminoglutethimide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000307	0.00341	CcSEcCtD
Aminoglutethimide—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000307	0.00578	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000304	0.00572	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000303	0.0057	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000297	0.00559	CbGpPWpGaD
Aminoglutethimide—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00029	0.00321	CcSEcCtD
Aminoglutethimide—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000286	0.00537	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000285	0.00535	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Corticotropin-releasing hormone—TLR4—chronic obstructive pulmonary disease	0.00028	0.00527	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.00028	0.00526	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000275	0.00517	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000271	0.0051	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000269	0.00506	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000267	0.00501	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000258	0.00485	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000249	0.00468	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000248	0.00466	CbGpPWpGaD
Aminoglutethimide—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000244	0.00271	CcSEcCtD
Aminoglutethimide—CYP2C19—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000237	0.00446	CbGpPWpGaD
Aminoglutethimide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000236	0.00261	CcSEcCtD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000235	0.00442	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000235	0.00442	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000233	0.00437	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000229	0.00431	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000226	0.00425	CbGpPWpGaD
Aminoglutethimide—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000225	0.00249	CcSEcCtD
Aminoglutethimide—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000222	0.00417	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000219	0.00412	CbGpPWpGaD
Aminoglutethimide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000219	0.00242	CcSEcCtD
Aminoglutethimide—CYP19A1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000217	0.00407	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000216	0.00406	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Corticotropin-releasing hormone—NOS3—chronic obstructive pulmonary disease	0.000214	0.00403	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000211	0.00396	CbGpPWpGaD
Aminoglutethimide—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000211	0.00233	CcSEcCtD
Aminoglutethimide—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00021	0.00395	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000208	0.00391	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000208	0.00391	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000208	0.0039	CbGpPWpGaD
Aminoglutethimide—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000206	0.00228	CcSEcCtD
Aminoglutethimide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000205	0.00386	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000203	0.00381	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.0002	0.00375	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000197	0.0037	CbGpPWpGaD
Aminoglutethimide—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000197	0.00218	CcSEcCtD
Aminoglutethimide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000196	0.00218	CcSEcCtD
Aminoglutethimide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000194	0.00365	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Corticotropin-releasing hormone—CXCL8—chronic obstructive pulmonary disease	0.00019	0.00357	CbGpPWpGaD
Aminoglutethimide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000188	0.00208	CcSEcCtD
Aminoglutethimide—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.00207	CcSEcCtD
Aminoglutethimide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.00207	CcSEcCtD
Aminoglutethimide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.00206	CcSEcCtD
Aminoglutethimide—CYP19A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000182	0.00342	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00018	0.00338	CbGpPWpGaD
Aminoglutethimide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000176	0.00195	CcSEcCtD
Aminoglutethimide—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000173	0.00324	CbGpPWpGaD
Aminoglutethimide—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000171	0.0019	CcSEcCtD
Aminoglutethimide—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000171	0.00189	CcSEcCtD
Aminoglutethimide—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000166	0.00313	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000164	0.00307	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000161	0.00302	CbGpPWpGaD
Aminoglutethimide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000159	0.00176	CcSEcCtD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000154	0.0029	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000153	0.00287	CbGpPWpGaD
Aminoglutethimide—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000153	0.00169	CcSEcCtD
Aminoglutethimide—CYP19A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000152	0.00286	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.00015	0.00282	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000149	0.0028	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000147	0.00277	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000144	0.0027	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000144	0.0027	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000144	0.0027	CbGpPWpGaD
Aminoglutethimide—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000143	0.00158	CcSEcCtD
Aminoglutethimide—CYP11A1—Corticotropin-releasing hormone—TGFB1—chronic obstructive pulmonary disease	0.000142	0.00266	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.000142	0.00266	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.00014	0.00263	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.00014	0.00262	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000138	0.00259	CbGpPWpGaD
Aminoglutethimide—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000137	0.00152	CcSEcCtD
Aminoglutethimide—Rash—Prednisone—chronic obstructive pulmonary disease	0.000136	0.00151	CcSEcCtD
Aminoglutethimide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000136	0.00151	CcSEcCtD
Aminoglutethimide—Headache—Prednisone—chronic obstructive pulmonary disease	0.000135	0.0015	CcSEcCtD
Aminoglutethimide—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000134	0.00253	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000132	0.00249	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	0.000132	0.00248	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.00013	0.00245	CbGpPWpGaD
Aminoglutethimide—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000128	0.00142	CcSEcCtD
Aminoglutethimide—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000126	0.00237	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000123	0.00232	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000122	0.00229	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000121	0.00227	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000116	0.00218	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000115	0.00216	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000115	0.00215	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000111	0.00208	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000106	0.002	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000106	0.002	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000106	0.002	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000106	0.00198	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000105	0.00198	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—GC—chronic obstructive pulmonary disease	0.000104	0.00195	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.0001	0.00188	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	9.82e-05	0.00185	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.63e-05	0.00181	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.42e-05	0.00177	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	9.02e-05	0.0017	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.97e-05	0.00169	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.85e-05	0.00166	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.84e-05	0.00166	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.72e-05	0.00164	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.29e-05	0.00156	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.19e-05	0.00154	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	7.95e-05	0.00149	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	7.67e-05	0.00144	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	7.59e-05	0.00143	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.47e-05	0.00141	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.37e-05	0.00139	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.27e-05	0.00137	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.27e-05	0.00137	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.05e-05	0.00133	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6.99e-05	0.00131	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	6.88e-05	0.00129	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—GC—chronic obstructive pulmonary disease	6.86e-05	0.00129	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.77e-05	0.00127	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	6.73e-05	0.00127	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.68e-05	0.00126	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.42e-05	0.00121	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.39e-05	0.0012	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.38e-05	0.0012	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.33e-05	0.00119	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.32e-05	0.00119	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	6.19e-05	0.00116	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	6.18e-05	0.00116	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	6.06e-05	0.00114	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	6.06e-05	0.00114	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.82e-05	0.00109	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	5.77e-05	0.00108	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	5.77e-05	0.00108	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.74e-05	0.00108	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.66e-05	0.00106	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.66e-05	0.00106	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—GCLC—chronic obstructive pulmonary disease	5.59e-05	0.00105	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.31e-05	0.000999	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.28e-05	0.000992	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.24e-05	0.000985	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.21e-05	0.00098	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.2e-05	0.000978	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	5.2e-05	0.000977	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	5.17e-05	0.000971	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—CTGF—chronic obstructive pulmonary disease	5.1e-05	0.000959	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.08e-05	0.000955	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5e-05	0.00094	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.93e-05	0.000928	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.7e-05	0.000884	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.43e-05	0.000833	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.37e-05	0.000822	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.07e-05	0.000766	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	4.02e-05	0.000757	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.02e-05	0.000755	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.92e-05	0.000737	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.87e-05	0.000727	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.86e-05	0.000726	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.81e-05	0.000716	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.75e-05	0.000704	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.7e-05	0.000696	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.68e-05	0.000692	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.6e-05	0.000677	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.45e-05	0.000649	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.42e-05	0.000643	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.42e-05	0.000642	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.39e-05	0.000638	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.38e-05	0.000635	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	3.33e-05	0.000626	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.11e-05	0.000585	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.11e-05	0.000584	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.09e-05	0.000582	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.87e-05	0.000539	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.67e-05	0.000501	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.6e-05	0.000488	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	2.59e-05	0.000488	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.56e-05	0.000482	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.47e-05	0.000463	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.41e-05	0.000453	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.39e-05	0.000449	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—ALB—chronic obstructive pulmonary disease	2.32e-05	0.000436	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.26e-05	0.000425	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.22e-05	0.000418	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.06e-05	0.000387	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2e-05	0.000376	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.92e-05	0.000361	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.86e-05	0.00035	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.82e-05	0.000342	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.8e-05	0.000338	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.68e-05	0.000315	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.64e-05	0.000308	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—ALB—chronic obstructive pulmonary disease	1.54e-05	0.000289	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.51e-05	0.000284	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.47e-05	0.000277	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.42e-05	0.000266	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.4e-05	0.000263	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.31e-05	0.000245	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.28e-05	0.00024	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.26e-05	0.000237	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.24e-05	0.000234	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.16e-05	0.000218	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.1e-05	0.000206	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.09e-05	0.000206	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.08e-05	0.000203	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	9.86e-06	0.000185	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.82e-06	0.000185	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.69e-06	0.000182	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.09e-06	0.000171	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.03e-06	0.00017	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.56e-06	0.000161	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.58e-06	0.000142	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.48e-06	0.000141	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	7.46e-06	0.00014	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	7.14e-06	0.000134	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.97e-06	0.000131	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.6e-06	0.000124	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	5.82e-06	0.000109	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	5.56e-06	0.000105	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	4.49e-06	8.44e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	4.29e-06	8.07e-05	CbGpPWpGaD
